JNCCN 360

Editor:

Jennifer R. Brown, MD, PhD

Advertisement

Advertisement

Ongoing CE Activities

CAR-T Cell Therapy for Blood Cancer Patients

Chronic Lymphocytic Leukemia Update, Issue 1, 2018

Chronic Lymphocytic Leukemia Update, Issue 1, 2019

City of Hope: State of the Art of Cancer Therapeutics: Focus on Chronic Lymphocytic Leukemia

Clinical Investigator Perspectives on Key Questions and Emerging Research in the Management of Lymphoma, Chronic Lymphocytic Leukemia and Multiple Myeloma

Consensus or Controversy? Clinical Investigator Perspectives on the Current and Future Management of Chronic Lymphocytic Leukemia

Conversations With Oncology Investigators: Bridging the Gap Between Research and Patient Care

Core Strategies in CLL to Mitigate Risks & Optimize Patient-Centered Care

Evolving Strategies in First-Line Chronic Lymphocytic Leukemia: Is There a Role for Chemoimmunotherapy?

Highlights from the 3rd Annual Seminar Series on Hematologic Malignancies & Precision Medicine: An Expert Q&A

Updates in the Management of CLL: Histologic Transformation and Relapsed/Refractory Disease

IGHV-Unmutated CLL: Gene Signature May Predict Outcomes After First-Line FCR

Clinical Advances: Individualizing Treatment for Chronic Lymphocytic Leukemia

Mitigating Side Effects and Optimizing Compliance With Oral Therapies in CLL

NCCN Guidelines Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2019

Recorded Presentations From the NCCN 2019 Annual Congress: Hematologic Malignancies™

Updates in the Management of Tumor Lysis Syndrome

Sections

NCCN Resources

Copyright © 2020 National Comprehensive Cancer Network, All Rights Reserved

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.